Cargando…
Iloprost modulates the immune response in systemic sclerosis
BACKGROUND: Iloprost has been suggested to possess anti-inflammatory and immunomodulating actions and it is widely use as a vasodilatator in systemic sclerosis (SSc). In this study we evaluate the effect of iloprost on immune response in SSc patients. To this extend we enrolled 15 women affected by...
Autores principales: | D'Amelio, Patrizia, Cristofaro, Maria A, D'Amico, Lucia, Veneziano, Luciana, Roato, Ilaria, Sassi, Francesca, Bisignano, Giuseppina, Saracco, Marta, Pellerito, Raffaele, Patanè, Salvatore, Ferracini, Riccardo, Pescarmona, Gian P, Isaia, Giovanni C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018379/ https://www.ncbi.nlm.nih.gov/pubmed/21159177 http://dx.doi.org/10.1186/1471-2172-11-62 |
Ejemplares similares
-
DKK-1 in prostate cancer diagnosis and follow up
por: D’Amelio, Patrizia, et al.
Publicado: (2014) -
Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study
por: Buondonno, Ilaria, et al.
Publicado: (2017) -
Osteoclasts Are Active in Bone Forming Metastases of Prostate Cancer Patients
por: Roato, Ilaria, et al.
Publicado: (2008) -
C-met inhibition blocks bone metastasis development induced by renal cancer stem cells
por: D'Amico, Lucia, et al.
Publicado: (2016) -
Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature
por: D′Amico, L, et al.
Publicado: (2013)